Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Pediatric Hematology
•
Iron Homeostasis
•
Primary Care
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
Answer from: at Community Practice
Excellent article on this topic: Baskin-Miller et al., PMID 39096194
Sign in or Register to read more
26026
Related Questions
In pure red cell aplasia, does peripheral blood-positive IgG for parvovirus have significance if persistently positive on retesting, but IgM and PCR are negative?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What parameters would you use to monitor and interpret iron levels in a hemochromatosis patient where ferritin is unreliable due to underlying chronic inflammation?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?